The use of natural compounds for the targeting and chemoprevention of ovarian cancer.

作者: Francesca Pistollato , Ruben Calderón Iglesias , Roberto Ruiz , Silvia Aparicio , Jorge Crespo

DOI: 10.1016/J.CANLET.2017.09.050

关键词: CisplatinTaxaneCancer researchBiologyCancerCombination chemotherapyStem cellChemotherapyAutophagyOvarian cancer

摘要: … the colchicine-binding site in tubulin. Also, compound 65 … tumor angiogenesis more efficiently than EGCG. Particularly, TF3 reduced angiogenesis induced by human ovarian carcinoma …

参考文章(118)
Susana Banerjee, Michael A Bookman, Martin Gore, None, Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs Emerging Therapeutic Targets in Ovarian Cancer. pp. 1- 33 ,(2011) , 10.1007/978-1-4419-7216-3_1
Francesca Pistollato, Elena Rampazzo, Luca Persano, Sara Abbadi, Chiara Frasson, Luca Denaro, Domenico D'Avella, David M. Panchision, Alessandro Della Puppa, Renato Scienza, Giuseppe Basso, Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate. Stem Cells. ,vol. 28, pp. 1918- 1929 ,(2010) , 10.1002/STEM.518
Marta Rossi, Eva Negri, Pagona Lagiou, Renato Talamini, Luigino Dal Maso, Maurizio Montella, Silvia Franceschi, Carlo La Vecchia, Flavonoids and ovarian cancer risk: A case–control study in Italy International Journal of Cancer. ,vol. 123, pp. 895- 898 ,(2008) , 10.1002/IJC.23549
MICHAL PASTOREK, VERONIKA SIMKO, MARTINA TAKACOVA, MONIKA BARATHOVA, MARIA BARTOSOVA, LUBA HUNAKOVA, OLGA SEDLAKOVA, SONA HUDECOVA, OLGA KRIZANOVA, FRANCK DEQUIEDT, SILVIA PASTOREKOVA, JAN SEDLAK, Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy International Journal of Oncology. ,vol. 47, pp. 51- 60 ,(2015) , 10.3892/IJO.2015.2987
Shizuka Seino, Keita Shibuya, Tsuyoshi Ohta, Manabu Seino, Chifumi Kitanaka, Shuhei Suzuki, Masashi Okada, Hiroyuki Takeda, Hirohisa Kurachi, Hirohisa Kurachi, Differential Contribution of ROS to Resveratrol-induced Cell Death and Loss of Self-renewal Capacity of Ovarian Cancer Stem Cells Anticancer Research. ,vol. 35, pp. 85- 96 ,(2015)
Ayesha B Alvero, Michele K Montagna, Vinicius Craveiro, Lanzhen Liu, Gil Mor, None, Distinct Subpopulations of Epithelial Ovarian Cancer Cells Can Differentially Induce Macrophages and T Regulatory Cells Toward a Pro-Tumor Phenotype American Journal of Reproductive Immunology. ,vol. 67, pp. 256- 265 ,(2012) , 10.1111/J.1600-0897.2011.01068.X
Miranda Y. Fong, Shunying Jin, Madhavi Rane, Raj K. Singh, Ramesh Gupta, Sham S. Kakar, Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer PLoS ONE. ,vol. 7, pp. e42265- ,(2012) , 10.1371/JOURNAL.PONE.0042265
Royce Mohan, Hans Hammers, Paola Bargagna-mohan, Xiaoguo Zhan, Christopher Herbstritt, Antonio Ruiz, Li Zhang, Art Hanson, Barry Conner, John Rougas, Victor Pribluda, Withaferin A is a potent inhibitor of angiogenesis Angiogenesis. ,vol. 7, pp. 115- 122 ,(2004) , 10.1007/S10456-004-1026-3
Taejong Song, Yoo-Young Lee, Chel Hun Choi, Tae-Joong Kim, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim, Histologic distribution of borderline ovarian tumors worldwide: a systematic review Journal of Gynecologic Oncology. ,vol. 24, pp. 44- 51 ,(2013) , 10.3802/JGO.2013.24.1.44
Katarzyna Terlikowska, Anna Witkowska, Malgorzata Zujko, Bozena Dobrzycka, Slawomir Terlikowski, Potential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer. International Journal of Molecular Sciences. ,vol. 15, pp. 21703- 21722 ,(2014) , 10.3390/IJMS151221703